Rapid blood test material, preparation method, and blood test method

Abstract

A rapid blood test material, a preparation method, and a blood test method. The rapid blood test material comprises the following raw materials in percentage: 60-80% of PMMA, 10-20% of a wetting agent, 0.6-0.8% of a biological enzyme, 0.2-0.4% of an indicator, 1-3% of a stabilizer, 0.8-1.2% of a surfactant, and 0.1-0.3% of nanoparticles. By using the rapid blood test material, blood test can be completed within 20 seconds, greatly shortening the time required from blood collection to obtaining results, and reducing blood test costs by 60% compared with conventional blood test methods; by optimizing the blood test process, a plurality of steps from blood collection to result comparison are reduced, so that the blood test process becomes simpler and more efficient; rapid blood test is suitable for emergency situations requiring immediate results or for routine screening; and the test can be completed by using only a very small number of blood samples.

Description

Rapid blood testing material, preparation method and blood testing method TECHNICAL FIELD

[0001] The present application relates to the technical field of rapid blood testing, in particular to a rapid blood testing material, a preparation method and a blood testing method. BACKGROUND

[0002] Blood testing, also known as blood detection or blood analysis, is a common medical diagnostic procedure that assesses a person's health by analyzing blood samples. Blood tests can provide important information about the functioning of body organs, disease diagnosis, disease risk, treatment effectiveness, and health status. Blood testing is a common medical examination method that assesses a person's health or diagnoses diseases by analyzing various components in blood samples. Blood testing can provide a wealth of information about the internal workings of the body, including but not limited to blood sugar levels, blood lipid conditions, organ function (such as liver and kidney function), inflammation markers, infection status (such as viral or bacterial infection), genetic disease risk, etc.

[0003] In Chinese patent CN117533662A, a blood glucose test paper box for endocrinology department is disclosed, which comprises a blood glucose test paper box body, a bottom box seat is arranged at the lower end of the blood glucose test paper box body, and a moisture-proof outer box is connected to the upper end of the bottom box seat in communication, a storage box is arranged in the moisture-proof outer box through a pulling structure, and the bottom of the storage box is inserted into the bottom box seat, a rack conveyor belt is installed inside the bottom box seat, and the rack conveyor belt is horizontally arranged below the storage box, a main drive gear shaft, a first driven gear shaft, and a second driven gear shaft are respectively connected to the inner ring of the rack conveyor belt through a rack structure, the blood glucose test paper box for endocrinology department is composed of a storage box, a moisture-proof outer box, and a rack conveyor belt, the blood glucose test paper is placed in the storage box, the moisture-proof outer box is used for moisture-proof protection, and the blood glucose test paper is sequentially conveyed out through the rack conveyor belt, which can effectively and conveniently take the blood glucose test paper and easily store the blood glucose test paper.

[0004] The above-mentioned application is the same as the existing technology in many parts of blood testing, which uses test paper for blood testing, and has the following disadvantages:

[0005] Many steps: multiple steps are required to complete blood collection and result comparison.

[0006] Long time: it may take a long time from blood collection to result.

[0007] High cost: test paper and other disposable equipment may cause high cost.

[0008] Waste blood: more blood samples may be required for detection. SUMMARY

[0009] In view of the defects of the prior art, the application provides a rapid blood testing material, a preparation method thereof and a blood testing method, which have the advantages of rapid blood testing, and solve the problem of blood taking and result comparison requiring multiple steps.

[0010] To achieve the above object, the application provides the following technical scheme: a rapid blood testing material, which comprises the following raw materials in percentage: PMMA 60-80%, humectant 10-20%, biological enzyme 0.6-0.8%, indicator 0.2-0.4%, stabilizer 1-3%, surfactant 0.8-1.2%, and nanoparticles 0.1-0.3%.

[0011] Further, the application comprises the following raw materials in percentage: PMMA 60%, humectant 10%, biological enzyme 0.6%, indicator 0.2%, stabilizer 1%, surfactant 0.8%, and nanoparticles 0.1%.

[0012] Further, the application comprises the following raw materials in percentage: PMMA 70%, humectant 15%, biological enzyme 0.7%, indicator 0.3%, stabilizer 2%, surfactant 1%, and nanoparticles 0.2%.

[0013] Further, the application comprises the following raw materials in percentage: PMMA 80%, humectant 20%, biological enzyme 0.8%, indicator 0.4%, stabilizer 3%, surfactant 1.2%, and nanoparticles 0.3%.

[0014] The application further provides a preparation method of the rapid blood testing material, which comprises the following steps:

[0015] S1, calculating the specific amount of each component according to the total amount required, and preparing the corresponding amount of raw materials;

[0016] S2, dissolving PMMA in an organic solvent to form a uniform solution;

[0017] S3, adding humectant, biological enzyme, indicator, stabilizer, surfactant and nanoparticles into the PMMA solution in sequence, and adding new raw materials after stirring each raw material;

[0018] S4, after all the components are completely mixed, pouring the mixed solution into a pre-prepared mold, and giving appropriate time and temperature according to the solidification conditions of PMMA and other components to make the material solidify and form;

[0019] S5, after solidification is completed, taking out the material from the mold, cutting it into a specific size and shape according to the requirement, and then cleaning and disinfecting it.

[0020] Further, in the mixing process of step S3, an ultrasonic generator is used for cooperation to avoid agglomeration.

[0021] Further, the preheating temperature of the curing in step S4 is 60-80℃, the curing temperature is 80-110℃, and the curing time is 1-3 hours.

[0022] Further, after the blood testing material is washed and disinfected in step S5, the prepared blood testing sheet is tested for performance, including but not limited to testing its biological compatibility, reaction sensitivity, and stability.

[0023] The application further provides a rapid blood testing method for the blood testing material, including the following steps:

[0024] S1 finger pricking: pricking the finger with a needle to obtain a trace amount of blood sample;

[0025] S2 blood testing sheet blood collection: dropping the blood sample obtained by pricking on a specific blood testing sheet;

[0026] S3 blood testing instrument: placing the blood testing sheet containing the blood sample into a blood testing instrument;

[0027] S4 analysis: analyzing the blood sample by the portable blood testing instrument and obtaining the blood testing result;

[0028] S5 result interpretation: according to the data analysis result provided by the blood testing instrument, the relevant indexes of the blood sample, such as the blood sugar level and the hemoglobin content, can be quickly obtained.

[0029] Further, the blood testing time of the blood testing instrument in step S3 is less than 20S, and after the blood is dropped and rested in step S2, the blood is allowed to react with the components on the blood testing sheet before being placed into the blood testing instrument.

[0030] Compared with the prior art, the technical scheme of the application has the following beneficial effects:

[0031] The rapid blood testing material, the preparation method and the blood testing method, using the rapid blood testing material can complete blood testing within 20 seconds, greatly shortening the time required from blood taking to obtaining results, compared with the traditional blood testing method, the rapid blood testing method can reduce the blood testing cost by up to 60%, by optimizing the blood testing process, reducing the multiple steps between blood taking and result comparison, so that the blood testing process becomes simpler and more efficient, the rapid blood testing method improves the work efficiency, is suitable for emergency situations or routine screening that require immediate results, due to the adoption of efficient design, only a small amount of blood sample can complete the detection, thereby reducing the demand for blood, through performance testing of the prepared blood testing material, ensuring that it has good biocompatibility, reducing adverse reactions caused by the material itself, through performance testing, ensuring that the blood testing material has sufficient reaction sensitivity, which can accurately detect the target substance in the blood sample, using a portable blood testing instrument, making the blood testing process more simple and easy to operate, reducing the operation difficulty, even non-professionals can easily get started. BRIEF DESCRIPTION OF DRAWINGS

[0032] Fig. 1 is a schematic diagram of the preparation method flow structure of the present application;

[0033] Fig. 2 is a schematic diagram of the blood testing method flow structure of the present application. DETAILED DESCRIPTION

[0034] The technical solutions in the embodiments of the present application will be described clearly and completely below with reference to the drawings in the embodiments of the present application. Obviously, the described embodiments are only a part of the embodiments of the present application, rather than all the embodiments. Based on the embodiments in the present application, all other embodiments obtained by those skilled in the art without creative labor fall within the scope of protection of the present application.

[0035] Embodiment one:

[0036] Please refer to Figs. 1-2, the rapid blood testing material in the present embodiment comprises the following percentage of raw materials: PMMA 60%, humectant 10%, biological enzyme 0.6%, indicator 0.2%, stabilizer 1%, surfactant 0.8%, and nanoparticles 0.1%.

[0037] In the present embodiment,

[0038] The biological enzyme can accelerate the speed of specific biochemical reactions in the blood sample, thereby quickly obtaining the detection result. Enzymes have high specificity, which means they can target specific substrates or reactions, reducing cross-reactions and improving the accuracy of detection.

[0039] The indicator can react with specific components in the blood sample, producing color changes, making the results more intuitive and easy to read. The indicator can help accurately measure the concentration of certain components in the blood through the depth of color change.

[0040] Stabilizers can protect biological enzymes and other sensitive ingredients from inactivation during storage and use by inhibiting microbial growth and chemical degradation, helping to extend the shelf life of blood testing materials.

[0041] Surfactants can improve the surface properties of blood testing materials, making it easier for blood samples to be evenly distributed on the material. It helps to improve the contact efficiency of various components in the blood sample with the detection material, thereby improving the reaction speed and detection sensitivity.

[0042] Nanoparticles can enhance detection signals, improve detection sensitivity and accuracy. The high surface-to-volume ratio of nanoparticles can provide more reaction sites, thereby improving reaction efficiency. Depending on the type and functionalization of nanoparticles, they can be designed to have specific targeting or catalytic activity to enhance the specificity of detection.

[0043] The application also proposes a preparation method of rapid blood testing materials, comprising the following steps:

[0044] S1 Calculate the specific amount of each component according to the total amount required, and prepare the corresponding amount of raw materials;

[0045] S2 Dissolve PMMA in an organic solvent to form a uniform solution;

[0046] S3 Add wetting agent, biological enzyme, indicator, stabilizer, surfactant and nanoparticle to the PMMA solution in turn, and add new raw materials after stirring each raw material;

[0047] S4 After all components are completely mixed, pour the mixed solution into the pre-prepared mold according to the solidification conditions of PMMA and other components, give appropriate time and temperature to let the material solidify and shape;

[0048] S5 After solidification is completed, the material is taken out from the mold, and cut into specific size and shape according to needs, and then washed and sterilized.

[0049] Among them, in the mixing process of step S3, ultrasonic generator is used for cooperation to avoid agglomeration.

[0050] Among them, the preheating temperature of solidification in step S4 is 60℃, the solidification temperature is 80℃, and the solidification time is 1 hour.

[0051] Among them, after the prepared blood testing materials are washed and sterilized, the performance of the prepared blood testing materials is tested, including but not limited to testing its biological compatibility, reaction sensitivity and stability.

[0052] In this embodiment,

[0053] Ultrasonic-assisted mixing ensures uniform dispersion of all ingredients, preventing agglomeration of raw materials, especially sensitive components like nanoparticles and biological enzymes.

[0054] Preheating temperature: A preheating temperature of 60°C helps to preheat the materials, remove moisture and air bubbles, and activate certain chemical components, preparing for the curing process.

[0055] Curing temperature: A curing temperature of 80°C is crucial to ensure that PMMA and other components are fully polymerized and cross-linked, promoting chemical reactions and forming a stable material structure.

[0056] Curing time: A curing time of 1 hour is determined based on the thickness of the material and the required mechanical strength, ensuring complete curing and achieving the desired performance.

[0057] The application also proposes a rapid blood testing material and method, including the following steps:

[0058] S1 Finger prick: Use a needle to prick the finger to obtain a small amount of blood sample;

[0059] S2 Blood test sheet blood collection: Drop the blood sample obtained after pricking on a specific blood test sheet;

[0060] S3 Put into blood testing instrument: Put the blood test sheet containing the blood sample into the blood testing instrument;

[0061] S4 Analysis: The portable blood testing instrument analyzes the blood sample and gives the blood test result;

[0062] S5 Result interpretation: According to the data analysis result provided by the blood testing instrument, the relevant indicators of the blood sample can be quickly obtained, such as blood glucose level and hemoglobin content.

[0063] In step S3, the blood testing time of the blood testing instrument is less than 20 seconds, and in step S2, the blood is allowed to react with the components on the blood test sheet after standing and then put into the blood testing instrument.

[0064] In this embodiment, the short standing time allows the necessary chemical reaction between the blood and the detection components on the blood test sheet, which is crucial to ensure the accuracy of the test results.

[0065] Example 2:

[0066] Please refer to Figures 1-2, a rapid blood testing material in this embodiment, including the following percentage of raw materials: PMMA 70%, humectant 15%, biological enzyme 0.7%, indicator 0.3%, stabilizer 2%, surfactant 1%, nanoparticles 0.2%.

[0067] In this embodiment,

[0068] Biological enzymes can accelerate the speed of specific biochemical reactions in blood samples, resulting in rapid detection results. Enzymes have high specificity, which means they can target specific substrates or reactions, reducing cross-reactions and improving the accuracy of detection.

[0069] Indicators can react with specific components in blood samples, producing color changes that make results more intuitive and easy to read. Indicators can help accurately measure the concentration of certain components in blood by the depth of color change.

[0070] Stabilizers can protect biological enzymes and other sensitive components from inactivation during storage and use, helping to extend the shelf life of blood testing materials by inhibiting microbial growth and chemical degradation.

[0071] Surfactants can improve the surface properties of blood testing materials, making it easier for blood samples to be evenly distributed on the material. This helps improve the contact efficiency of various components in the blood sample with the detection material, thereby improving reaction speed and detection sensitivity.

[0072] Nanoparticles can enhance detection signals, improving the sensitivity and accuracy of detection. The high surface-to-volume ratio of nanoparticles can provide more reaction sites, thereby improving reaction efficiency. Depending on the type and functionality of the nanoparticles, they can be designed to have specific targeting or catalytic activity to enhance the specificity of detection.

[0073] The present application further proposes a preparation method of rapid blood testing material, comprising the following steps:

[0074] S1 Calculate the specific amount of each component according to the total amount required, and prepare the corresponding amount of raw materials;

[0075] S2 Dissolve PMMA in an organic solvent to form a uniform solution;

[0076] S3 Add wetting agent, biological enzyme, indicator, stabilizer, surfactant and nanoparticle to the PMMA solution in sequence, and add new raw materials after stirring each raw material;

[0077] S4 After all components are completely mixed and uniform, pour the mixed solution into the pre-prepared mold, and give appropriate time and temperature according to the solidification conditions of PMMA and other components to allow the material to solidify and form;

[0078] S5 After solidification is complete, remove the material from the mold, cut it to a specific size and shape as needed, and then clean and disinfect it.

[0079] In the mixing process of step S3, an ultrasonic generator is used to avoid agglomeration.

[0080] In step S4, the preheating temperature for curing is 70°C, the curing temperature is 95°C, and the curing time is 2 hours.

[0081] In step S5, after cleaning and disinfecting the prepared blood test materials, the prepared blood test strips are then subjected to performance testing, including but not limited to testing their biocompatibility, reaction sensitivity, and stability.

[0082] In this embodiment,

[0083] Ultrasonic-assisted mixing ensures that all components are evenly dispersed, preventing raw material agglomeration, especially for sensitive components such as nanoparticles and bio-enzymes.

[0084] Preheating temperature: A preheating temperature of 70°C helps to preheat the material, remove moisture and air bubbles, and activate certain chemical components to prepare for the curing process.

[0085] Curing temperature: A curing temperature of 95℃ is key to ensuring that PMMA and other components fully polymerize and crosslink. This temperature range can promote the chemical reaction and form a stable material structure.

[0086] Curing time: The 2-hour curing time is determined based on the thickness of the material and the required mechanical strength to ensure that the material is fully cured and achieves the expected performance.

[0087] This application also proposes a rapid blood testing method for blood samples, including the following steps:

[0088] S1 fingertip pricking: Using a needle to prick the fingertip to obtain a small blood sample;

[0089] S2 blood sample collection: The blood sample obtained after pricking the needle is dripped onto a specific blood sample pad;

[0090] S3 Place the blood sample into the blood analyzer: Place the blood sample smear into the blood analyzer;

[0091] S4 Analysis: A portable blood analyzer analyzes blood samples and provides the results;

[0092] S5 Result Interpretation: Based on the data analysis results provided by the blood analyzer, relevant indicators of the blood sample, such as blood glucose level and hemoglobin content, can be quickly determined.

[0093] In step S3, the blood testing time of the blood analyzer is less than 20 seconds. In step S2, after the blood is dripped in, it is left to stand to allow the blood to react with the components on the blood test strip before being placed into the blood analyzer.

[0094] In this embodiment, the brief settling time allows the blood to undergo the necessary chemical reaction with the test components on the blood smear, which is crucial for ensuring the accuracy of the test results.

[0095] Example Three:

[0096] Referring to FIGS. 1-2, a rapid blood testing material in this embodiment includes the following raw materials in the following percentages: PMMA 80%, humectant 20%, biological enzyme 0.8%, indicator 0.4%, stabilizer 3%, surfactant 1.2%, and nanoparticles 0.3%.

[0097] In this embodiment,

[0098] Biological enzymes can accelerate the speed of specific biochemical reactions in blood samples, thereby quickly obtaining detection results. Enzymes have high specificity, which means they can target specific substrates or reactions, reducing cross-reactions and improving detection accuracy.

[0099] Indicators can react with specific components in blood samples, producing color changes that make results more intuitive and easy to read. The intensity of the color change can help accurately measure the concentration of certain components in the blood.

[0100] Stabilizers can protect biological enzymes and other sensitive components from inactivation during storage and use, helping to extend the shelf life of the blood testing material by inhibiting microbial growth and chemical degradation.

[0101] Surfactants can improve the surface properties of the blood testing material, making it easier for blood samples to be evenly distributed on the material. This helps improve the contact efficiency of various components in the blood sample with the detection material, thereby improving reaction speed and detection sensitivity.

[0102] Nanoparticles can enhance detection signals, improving detection sensitivity and accuracy. The high surface-to-volume ratio of nanoparticles provides more reaction sites, thereby improving reaction efficiency. Depending on the type and functionality of the nanoparticles, they can be designed to have specific targeting or catalytic activity to enhance detection specificity.

[0103] The present application also proposes a method for preparing a rapid blood testing material, comprising the following steps:

[0104] S1 Calculate the specific amount of each component based on the total amount required, and prepare the corresponding amount of raw materials;

[0105] S2 Dissolve PMMA in an organic solvent to form a uniform solution;

[0106] S3 Add humectant, biological enzyme, indicator, stabilizer, surfactant, and nanoparticles to the PMMA solution one by one, and add new raw materials after stirring each individual raw material;

[0107] S4 After all the ingredients are thoroughly mixed, pour the mixture into the pre-prepared mold. According to the curing conditions of PMMA and other ingredients, give appropriate time and temperature to let the material solidify and form;

[0108] S5 After solidification is complete, remove the material from the mold and cut it to the desired size and shape as needed, then clean and disinfect it.

[0109] Among them, in step S3, ultrasonic generator is used to avoid agglomeration.

[0110] Among them, in step S4, the preheating temperature for curing is 80℃, the curing temperature is 110℃, and the curing time is 3 hours.

[0111] Among them, in step S5, after the blood testing material is cleaned and disinfected, the performance of the prepared blood testing sheet is tested, including but not limited to testing its biological compatibility, reaction sensitivity, and stability.

[0112] In this embodiment,

[0113] Ultrasonic-assisted mixing ensures that all ingredients are uniformly dispersed and avoids agglomeration of raw materials, especially for sensitive ingredients such as nanoparticles and biological enzymes.

[0114] Preheating temperature: A preheating temperature of 80℃ helps to preheat the material, remove moisture and bubbles, and activate certain chemical components, preparing for the curing process.

[0115] Curing temperature: A curing temperature of 110℃ is crucial to ensure that PMMA and other ingredients are fully polymerized and cross-linked. This temperature range promotes chemical reactions and forms a stable material structure.

[0116] Curing time: A curing time of 3 hours is determined based on the thickness of the material and the required mechanical strength, ensuring that the material is fully cured and achieves the desired performance.

[0117] The present application also proposes a rapid blood testing method, including the following steps:

[0118] S1 Finger prick: Use a needle to prick the finger to obtain a small amount of blood sample;

[0119] S2 Blood testing sheet blood collection: Drop the blood sample obtained after pricking on a specific blood testing sheet;

[0120] S3 Put into blood testing instrument: Put the blood testing sheet containing the blood sample into the blood testing instrument;

[0121] S4 Analysis: The portable blood testing instrument analyzes the blood sample and gives the blood testing result;

[0122] S5 result interpretation: according to the data analysis result provided by the blood testing instrument, the relevant indicators of the blood sample can be quickly known, such as blood glucose level, hemoglobin content.

[0123] In the step S3, the blood testing time of the blood testing instrument is less than 20S, and after the blood is dropped and placed, the blood reacts with the components on the blood testing sheet, and then is put into the blood testing instrument.

[0124] In the embodiment, the short standing time allows the blood to react with the detection components on the blood testing sheet, which is crucial for ensuring the accuracy of the detection result.

[0125] The beneficial effects of the above embodiment are that the rapid blood testing material can complete blood testing within 20 seconds, greatly shortening the time required from blood taking to result, and compared with the traditional blood testing method, the rapid blood testing method can reduce the blood testing cost by up to 60%, optimizes the blood testing process, reduces the multiple steps between blood taking and result comparison, makes the blood testing process simpler and more efficient, improves the work efficiency, is suitable for emergency situations or routine screening that require immediate results, and due to the use of efficient design, only a small amount of blood sample is required for detection, thereby reducing the demand for blood, through performance testing of the prepared blood testing material, good biological compatibility is ensured, reducing adverse reactions caused by the material itself, through performance testing, it is ensured that the blood testing material has sufficient reaction sensitivity and can accurately detect the target substance in the blood sample, the use of portable blood testing instrument makes the blood testing process more simple and easy to operate, reduces the operation difficulty, even non-professionals can easily master it.

[0126] It should be noted that in this paper, relationship terms such as first and second are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between the entities or operations. Moreover, the terms "include", "contain" or any other variants thereof are intended to cover non-exclusive inclusion, so that the process, method, article or equipment including a series of elements not only includes those elements, but also includes other elements not explicitly listed or inherent to such process, method, article or equipment. Without more limitations, the element defined by the statement "including a…" does not exclude the presence of another identical element in the process, method, article or equipment including the element.

[0127] Although the embodiments of the present application have been shown and described, it will be understood by those of ordinary skill in the art that various changes, modifications, replacements and variations can be made to these embodiments without departing from the principles and spirits of the present application.

Claims

1. A rapid blood testing material, characterized by: The raw materials include the following percentage ratio: PMMA 60-80%, humectant 10-20%, biological enzyme 0.6-0.8%, indicator 0.2-0.4%, stabilizer 1-3%, surfactant 0.8-1.2%, and nanoparticles 0.1-0.3%.

2. The rapid blood testing material of claim 1, wherein: The raw materials include the following percentage ratio: PMMA 60%, humectant 10%, biological enzyme 0.6%, indicator 0.2%, stabilizer 1%, surfactant 0.8%, and nanoparticles 0.1%.

3. The rapid blood testing material of claim 1, wherein: The raw materials include the following percentage ratio: PMMA 70%, humectant 15%, biological enzyme 0.7%, indicator 0.3%, stabilizer 2%, surfactant 1%, and nanoparticles 0.2%.

4. The rapid blood testing material of claim 1, wherein: The raw materials include the following percentage ratio: PMMA 80%, humectant 20%, biological enzyme 0.8%, indicator 0.4%, stabilizer 3%, surfactant 1.2%, and nanoparticles 0.3%.

5. A method for preparing a rapid blood testing material comprising a rapid blood testing material according to any one of claims 1 to 4, characterized in that: The steps include: S1. Calculate the specific amount of each component according to the total amount required, and prepare the corresponding amount of raw materials; S2. Dissolve PMMA in an organic solvent to form a uniform solution; S3. Add humectant, biological enzyme, indicator, stabilizer, surfactant, and nanoparticles to the PMMA solution one by one, and after stirring each individual raw material, add the new raw material; S4. After all components are thoroughly mixed, pour the mixture into a pre-prepared mold, and according to the curing conditions of PMMA and other components, give appropriate time and temperature to allow the material to solidify and form; S5. After solidification is complete, remove the material from the mold, and according to the needs, cut it into specific size and shape, and then clean and disinfect.

6. The method of claim 5, wherein the rapid blood testing material is prepared by the steps of: In the mixing process of step S3, an ultrasonic generator is used to avoid agglomeration.

7. The method for preparing a rapid blood testing material according to claim 1, characterized in that: In step S4, the preheating temperature for solidification is 60-80°C, the solidification temperature is 80-110°C, and the solidification time is 1-3 hours.

8. The rapid blood testing material, the preparation method and the blood testing method according to claim 1, characterized in that: After cleaning and disinfecting the completed blood testing material, the performance of the prepared blood testing sheet is tested, including but not limited to testing its biological compatibility, reaction sensitivity, and stability.

9. A rapid blood testing material and method of testing blood comprising a rapid blood testing material according to any one of claims 1 to 4 and a method of preparing a rapid blood testing material according to any one of claims 5 to 8, characterised in that: The steps include: S1. Finger pricking: use a needle to prick the finger to obtain a small amount of blood sample; S2. Blood testing sheet blood collection: drop the blood sample obtained after pricking on a specific blood testing sheet; S3. Put into blood testing instrument: put the blood testing sheet containing the blood sample into the blood testing instrument; S4. Analysis: the portable blood testing instrument analyzes the blood sample and gives the blood testing result; S5. Result interpretation: according to the data analysis result provided by the blood testing instrument, the relevant indicators of the blood sample, such as blood glucose level and hemoglobin content, can be quickly known.

10. The method of claim 9, wherein the rapid blood testing material is a lateral flow test strip. In step S3, the blood testing time of the blood testing instrument is less than 20S, and in step S2, after the blood is dropped and allowed to react with the components on the blood testing sheet, it is then put into the blood testing instrument.

Images